CAS 2685873-44-1

Fórmula: C30H35N3O5

InChI: InChI=1S/C30H35N3O5/c1-5-33(24-10-12-38-13-11-24)27-16-23(21-6-8-22(9-7-21)30(36)37)15-25(20(27)4)28(34)31-17-26-18(2)14-19(3)32-29(26)35/h6-9,14-16,24H,5,10-13,17H2,1-4H3,(H,31,34)(H,32,35)(H,36,37)

Clave InChI: MIEXIPQREXYLRA-UHFFFAOYSA-N

SMILES: CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)C(=O)O

Tazemetostat de(methyl morpholine)-COOH

CAS: 2685873-44-1

Tazemetostat de(methyl morpholine)-COOH

Fórmula: C₃₀H₃₅N₃O₅

Pureza: 98%

Peso molecular: 517.63

Ref: 54-OR1067144

Tazemetostat de(methyl morpholine)-COOH

CAS: 2685873-44-1

Tazemetostat de(methyl morpholine)-COOH (compound 7), a PROTAC ligand for EZH2, facilitates the synthesis of PROTACs that target this enzyme.

Fórmula: C₃₀H₃₅N₃O₅

Pureza: 98%

Forma y color: Solid

Peso molecular: 517.616

Ref: TM-T77940

Tazemetostat de(methyl morpholine)-COOH

CAS: 2685873-44-1

Fórmula: C₃₀H₃₅N₃O₅

Pureza: 98.50%

Peso molecular: 517.616

Ref: IN-DA024RTA

Tazemetostat de(methyl morpholine)-COOH

CAS: 2685873-44-1

Tazemetostat de(methyl morpholine)-COOH

Fórmula: C₃₀H₃₅N₃O₅

Pureza: 98%

Peso molecular: 517.62

Ref: IN-DG01615415